Trulieve Cannabis (NYSE:TRLV) CEO Kim Rivers Sells 400,000 Shares

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 400,000 shares of the stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.17, for a total transaction of $3,268,000.00. Following the transaction, the chief executive officer owned 1,913,724 shares in the company, valued at approximately $15,635,125.08. The trade was a 17.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Up 0.7%

NYSE:TRLV opened at $8.56 on Friday. Trulieve Cannabis Corp. has a fifty-two week low of $3.50 and a fifty-two week high of $13.28.

Analyst Ratings Changes

A number of equities research analysts have issued reports on TRLV shares. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings started coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.